JP2025506667A5 - - Google Patents

Info

Publication number
JP2025506667A5
JP2025506667A5 JP2024547925A JP2024547925A JP2025506667A5 JP 2025506667 A5 JP2025506667 A5 JP 2025506667A5 JP 2024547925 A JP2024547925 A JP 2024547925A JP 2024547925 A JP2024547925 A JP 2024547925A JP 2025506667 A5 JP2025506667 A5 JP 2025506667A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
represented
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506667A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012879 external-priority patent/WO2023154499A1/en
Publication of JP2025506667A publication Critical patent/JP2025506667A/ja
Publication of JP2025506667A5 publication Critical patent/JP2025506667A5/ja
Pending legal-status Critical Current

Links

JP2024547925A 2022-02-14 2023-02-13 エモパミル結合タンパク質阻害剤及びその使用 Pending JP2025506667A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263309923P 2022-02-14 2022-02-14
US63/309,923 2022-02-14
PCT/US2023/012879 WO2023154499A1 (en) 2022-02-14 2023-02-13 Emopamil-binding protein inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025506667A JP2025506667A (ja) 2025-03-13
JP2025506667A5 true JP2025506667A5 (https=) 2026-02-24

Family

ID=85505736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547925A Pending JP2025506667A (ja) 2022-02-14 2023-02-13 エモパミル結合タンパク質阻害剤及びその使用

Country Status (5)

Country Link
US (1) US20250152574A1 (https=)
EP (1) EP4479384A1 (https=)
JP (1) JP2025506667A (https=)
CN (1) CN119731156A (https=)
WO (1) WO2023154499A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202523666A (zh) * 2023-08-23 2025-06-16 美商百健Ma公司 依莫帕米結合蛋白抑制劑及其用途
WO2025049275A1 (en) * 2023-08-25 2025-03-06 Biogen Ma Inc. Emopamil-binding protein inhibitors and uses thereof
IL326831A (en) * 2023-08-28 2026-04-01 Genzyme Corp Pyrazolyl compounds as amofamyl-binding protein inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10082496B2 (en) * 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
MA44037B1 (fr) * 2016-06-06 2020-03-31 Arena Pharm Inc Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de troubles associés à ceux-ci

Similar Documents

Publication Publication Date Title
JP2025506667A5 (https=)
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
HRP20241159T1 (hr) Heterociklički agonisti za glp-1
JP2022553376A5 (https=)
JP2019530732A (ja) 免疫モジュレータとして有用な対称または半対称化合物
JP2014506917A (ja) 新規キナーゼ阻害剤
CA2672373A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
JP2022552324A5 (https=)
JP2014506599A5 (https=)
JP2010538076A5 (https=)
JP2022553832A5 (https=)
JP2023521351A5 (https=)
RU2015143718A (ru) N-ацил-N'-(пиридин-2-ил) карбамиды и их аналоги, проявляющие противораковую и антипролиферативную активность
JP2011502956A5 (https=)
JP2011126891A (ja) 2−アシルアミノ−4−フェニルチアゾール誘導体の合成中間体
JP2015514794A5 (https=)
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2024525797A5 (https=)
KR20120049940A (ko) 키나제 억제제로서의 헤테로아릴 화합물
JP2004532227A5 (https=)
RU2005136368A (ru) Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний
JP2016516724A5 (https=)
RU2019136279A (ru) C5 -Анилинохиназолиновые соединения и их использование в лечении рака
JP2016532669A5 (https=)
JP2005506290A5 (https=)